Skip to main content

Development of Targeted Nanomedicines via Machine Learning Processes

By Daniel Heller

Memorial Sloan Kettering Cancer Center

Download (PDF)

Licensed under

Published on


Nano WG February 21, 2019

Description: We are using data science to facilitate the development of nanoparticle drugs incorporating kinase inhibitors with diverse chemical structures. Doing this work inspired us to bring together the nanoinformatics community and to better understand how both data and information sciences can be used in nanomedicine and nanoparticle synthesis.

Cite this work

Researchers should cite this work as follows:

  • Daniel Heller (2019), "Development of Targeted Nanomedicines via Machine Learning Processes,"

    BibTex | EndNote


Mervi Heiskanen

National Cancer Institute